Kan biosys Revenue and Competitors
Estimated Revenue & Valuation
- Kan biosys's estimated annual revenue is currently $8.2M per year.
- Kan biosys's estimated revenue per employee is $77,500
Employee Data
- Kan biosys has 106 Employees.
- Kan biosys grew their employee count by 8% last year.
Kan biosys's People
| Name | Title | Email/Phone |
|---|
Kan biosys Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12M | 155 | -4% | N/A | N/A |
#2 | $17.3M | 223 | 18% | N/A | N/A |
#3 | $11.1M | 143 | 34% | N/A | N/A |
#4 | $8.2M | 106 | 8% | N/A | N/A |
#5 | $9.5M | 123 | 10% | N/A | N/A |
#6 | $21.2M | 273 | 8% | N/A | N/A |
#7 | $12M | 155 | 8% | N/A | N/A |
#8 | $18.9M | 244 | 5% | N/A | N/A |
#9 | $12.5M | 161 | 9% | N/A | N/A |
#10 | $20.5M | 264 | 8% | N/A | N/A |
What Is Kan biosys?
Kan biosys - we build trust with focussed technology. A specialized agri-biotech company with a vision to go global aiming for high yields, reducing toxins and residues. Innovative certified products for nutrition, pest and soil health management. Award winning bio-solutions, biofertilizers and biopesticides used in 8 countries.
keywords:N/A
N/A
Total Funding
106
Number of Employees
$8.2M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Kan biosys News
... Camson Biotechnologies Ltd, Andermatt Biocontrol AG, Kan Biosys Pvt. Ltd., Futureco Bioscience S.A., Kilpest India Ltd, BioSafe Systems,...
... EuroChem Agro GmbH; Gujarat State Fertilizers & Chemicals Limited; Kan Biosys Pvt. Ltd.; Kiwa Bio-Tech Products Group Corporation;...
Kan Biosys (India); Mapleton Agri Biotech Pty Ltd (Australia); Seipasa (Spain); AgriLife (India); Manidharma Biotech Pvt Ltd (India); Biomax...
Other Companies in Pune
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.7M | 106 | -20% | N/A |
#2 | $11M | 107 | 10% | N/A |
#3 | $15.7M | 108 | N/A | N/A |
#4 | $7.8M | 108 | 9% | N/A |
#5 | $13.6M | 109 | 58% | N/A |